SAN DIEGO COUNTY - News from Aug. 10, 1989
- Share via
* Progenx, a start-up San Diego biotechnology company that is trying to develop therapeutic drugs, announced it has raised $6.4 million in a secondary round of venture capital financing, bringing to $9.6 million the amount of venture funds it has raised since its founding in September, 1987.
Investors included Venrock Associates, Merrill Lynch Venture Capital, and Burr, Egan & Deleage. Merrill Lynch’s Robert Curry has been added to the Progenx board of directors.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
